Nov. 26, 2014
Plant Health Care plc (AIM: PHC) has engaged LHA, a full-service investor relations agency to build awareness for its business and growth potential within the U.S. investment community.
Plant Health Care has engaged LHA as it seeks to expand the commercialisation of its second generation Harpin αβ and Myconate-based products and develop third-generation technology platforms and products.
Chris Richards, Chairman of Plant Health Care, said, "We are pleased to have appointed LHA to support the Company in reaching out to potential new investors. With our headquarters in the United States and our largest target markets in the Americas, we believe that North American investors will take an active interest in Plant Health Care as an exciting growth company in the attractive ag biotech sector. LHA has an impressive track record raising the profile of emerging growth companies like Plant Health Care, including experience supporting London-listed companies."
"We are very excited to have Plant Health Care as a new client," stated John Heilshorn, co-founding partner of LHA. "We look forward to introducing their dynamic team and compelling growth story to the U.S. investment community in the upcoming months. Their biostimulant products represent an emerging technology within the agricultural industry, offering both yield enhancement and a friendly environmental footprint."
Founded in 1984, LHA operates from offices in New York, Boston,San Francisco and Los Angeles. The firm specialises in building investment community awareness and support for small cap growth companies.
View More